Share Email Print
cover

Proceedings Paper

Development of novel magnetic nanoparticles for hyperthermia cancer therapy
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

Advances in magnetic nanoparticle hyperthermia are opening new doors in cancer therapy. As a standalone or adjuvant therapy this new modality has the opportunity significantly advance thermal medicine. Major advantages of using magnetic magnetite (Fe3O4) nanoparticles are their highly localized power deposition and the fact that the alternating magnetic fields (AMF) used to excite them can penetrate deeply into the body without harmful effect. One limitation, however, which hinders the technology, is the problem of inductive heating of normal tissue by the AMF if the frequency and fields strength are not appropriately matched to the tissue. Restricting AMF amplitude and frequency limits the heat dose which can be selectively applied to cancerous tissue via the magnetic nanoparticle, thus lowering therapeutic effect. In an effort to address this problem, particles with optimized magnetic properties must be developed. Using particles with higher saturation magnetizations and coercivity will enhance hysteresis heating increasing particle power density at milder AMF strengths and frequencies. In this study we used oil in water microemulsions to develop nanoparticles with zero-valent Fe cores and magnetite shells. The superior magnetic properties of zero-valent Fe give these particles the potential for improved SAR over pure magnetite particles. Silane and subsequently dextran have been attached to the particle surface in order to provide a biocompatible surfactant coating. The heating capability of the particles was tested in-vivo using a mouse tumor model. Although we determined that the final stage of synthesis, purification of the dextran coated particles, permits significant corrosion/oxidation of the iron core to hematite, the particles can effectively heat tumor tissue. Improving the purification procedure will allow the generation Fe/Fe3O4 with superior SAR values.

Paper Details

Date Published: 23 February 2011
PDF: 10 pages
Proc. SPIE 7901, Energy-based Treatment of Tissue and Assessment VI, 790115 (23 February 2011); doi: 10.1117/12.876514
Show Author Affiliations
Shiraz M. Cassim, Dartmouth College (United States)
Andrew J. Giustini, Dartmouth College (United States)
Dartmouth Medical School (United States)
Ian Baker, Dartmouth College (United States)
P. Jack Hoopes, Dartmouth College (United States)
Dartmouth Medical School (United States)


Published in SPIE Proceedings Vol. 7901:
Energy-based Treatment of Tissue and Assessment VI
Thomas P. Ryan, Editor(s)

© SPIE. Terms of Use
Back to Top